Barkhof F - Search Results

1

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition.

Manson SC, Wegner C, Filippi M, Barkhof F, Beckmann C, Ciccarelli O, De Stefano N, Enzinger C, Fazekas F, Agosta F, Gass A, Hirsch J, Johansen-Berg H, Kappos L, Korteweg T, Polman C, Mancini L, Manfredonia F, Marino S, Miller DH, Montalban X, Palace J, Rocca M, Ropele S, Rovira A, Smith S, Thompson A, Thornton J, Yousry T, Frank JA, Matthews PM. Manson SC, et al. Among authors: barkhof f. Exp Brain Res. 2008 May;187(1):25-31. doi: 10.1007/s00221-008-1276-1. Epub 2008 Jan 31. Exp Brain Res. 2008. PMID: 18236036 Free PMC article.

2

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Miller DH, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):683-8. doi: 10.1136/jnnp.54.8.683. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940938 Free PMC article.

3

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. van Walderveen MA, et al. Among authors: barkhof f. Neurology. 1995 Sep;45(9):1684-90. doi: 10.1212/wnl.45.9.1684. Neurology. 1995. PMID: 7675227

4

Multiple sclerosis therapy. A practical guide.

van Oosten BW, Truyen L, Barkhof F, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Drugs. 1995 Feb;49(2):200-12. doi: 10.2165/00003495-199549020-00005. Drugs. 1995. PMID: 7729328 Review.

5

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: barkhof f. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

6

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs.

Nauta JJ, Thompson AJ, Barkhof F, Miller DH. Nauta JJ, et al. Among authors: barkhof f. J Neurol Sci. 1994 Mar;122(1):6-14. doi: 10.1016/0022-510x(94)90045-0. J Neurol Sci. 1994. PMID: 8195804

7

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.

Miller DH, Barkhof F, Nauta JJ. Miller DH, et al. Among authors: barkhof f. Brain. 1993 Oct;116 ( Pt 5):1077-94. doi: 10.1093/brain/116.5.1077. Brain. 1993. PMID: 8221048

8

[Treatment of multiple sclerosis using recombinant interferon-beta].

Polman CH, Barkhof F, van Loenen AC, Lucas CJ, Koetsier JC. Polman CH, et al. Among authors: barkhof f. Ned Tijdschr Geneeskd. 1994 Jan 1;138(1):7-10. Ned Tijdschr Geneeskd. 1994. PMID: 8289963 Clinical Trial. Dutch. No abstract available.

9

Database for serial magnetic resonance imaging in multiple sclerosis.

Barkhof F, Thompson AJ, Kappos L, Nauta JJ, Yousri T, Berry I, Scotti G, Appel B, Tofts PS, Miller DH. Barkhof F, et al. Neuroradiology. 1993;35(5):362-6. doi: 10.1007/BF00588371. Neuroradiology. 1993. PMID: 8327113

10

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Miller DH, et al. Among authors: barkhof f. Ann Neurol. 1996 Jan;39(1):6-16. doi: 10.1002/ana.410390104. Ann Neurol. 1996. PMID: 8572668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,452 results

Search Page